|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
CyberBiotech
|
1.4K |
551K |
0 |
07/04/26 |
| 07/04/26 |
ASX - By Stock
|
1.4K
|
551K
|
0
|
|
|
ASX - By Stock
|
OCC |
Re:
Upcoming Catalysts
|
|
CyberBiotech
|
17 |
5.2K |
1 |
17/03/26 |
| 17/03/26 |
ASX - By Stock
|
17
|
5.2K
|
1
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Strategic Update and HY26 Results
|
|
CyberBiotech
|
22 |
5.2K |
4 |
26/02/26 |
| 26/02/26 |
ASX - By Stock
|
22
|
5.2K
|
4
|
|
|
ASX - By Stock
|
OCC |
Re:
2024/2025 Catalysts
|
|
CyberBiotech
|
291 |
125K |
1 |
20/02/26 |
| 20/02/26 |
ASX - By Stock
|
291
|
125K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
Marine Biomedical Submits 510(k) Application to the U.S. FDA for PearlBone™
|
|
CyberBiotech
|
47 |
10K |
3 |
17/02/26 |
| 17/02/26 |
ASX - By Stock
|
47
|
10K
|
3
|
|
|
ASX - By Stock
|
OCC |
Marine Biomedical Submits 510(k) Application to the U.S. FDA for PearlBone™
|
|
CyberBiotech
|
47 |
10K |
30 |
17/02/26 |
| 17/02/26 |
ASX - By Stock
|
47
|
10K
|
30
|
|
|
ASX - By Stock
|
OCC |
Re:
Orthocell , Remplir the Global Bull Case
|
|
CyberBiotech
|
51 |
13K |
0 |
12/02/26 |
| 12/02/26 |
ASX - By Stock
|
51
|
13K
|
0
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: US Market and Operational Update
|
|
CyberBiotech
|
112 |
25K |
5 |
02/02/26 |
| 02/02/26 |
ASX - By Stock
|
112
|
25K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: US Market and Operational Update
|
|
CyberBiotech
|
112 |
25K |
5 |
02/02/26 |
| 02/02/26 |
ASX - By Stock
|
112
|
25K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Posts Seventh Straight Record Revenue Quarter
|
|
CyberBiotech
|
129 |
24K |
7 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
129
|
24K
|
7
|
|
|
ASX - By Stock
|
IMC |
Re:
Recovery soon
|
|
CyberBiotech
|
16 |
4.2K |
1 |
25/12/25 |
| 25/12/25 |
ASX - By Stock
|
16
|
4.2K
|
1
|
|
|
ASX - By Stock
|
IMC |
Re:
Countdown to Being Delisted from NASDAQ begins.
|
|
CyberBiotech
|
21 |
4.7K |
2 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
21
|
4.7K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
CyberBiotech
|
2.8K |
1.0M |
0 |
13/12/25 |
| 13/12/25 |
ASX - By Stock
|
2.8K
|
1.0M
|
0
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Uniformed Services University to Release Topline Data
|
|
CyberBiotech
|
47 |
9.1K |
4 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
47
|
9.1K
|
4
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change in substantial holding
|
|
CyberBiotech
|
15 |
2.3K |
0 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
15
|
2.3K
|
0
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change in substantial holding
|
|
CyberBiotech
|
15 |
2.3K |
1 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
15
|
2.3K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
CyberBiotech
|
2.8K |
1.4M |
2 |
03/12/25 |
| 03/12/25 |
ASX - By Stock
|
2.8K
|
1.4M
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
CyberBiotech
|
2.8K |
1.0M |
5 |
01/12/25 |
| 01/12/25 |
ASX - By Stock
|
2.8K
|
1.0M
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
CyberBiotech
|
2.8K |
1.4M |
7 |
18/11/25 |
| 18/11/25 |
ASX - By Stock
|
2.8K
|
1.4M
|
7
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change in substantial holding
|
|
CyberBiotech
|
2 |
677 |
1 |
12/11/25 |
| 12/11/25 |
ASX - By Stock
|
2
|
677
|
1
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Proposed issue of securities - IMC
|
|
CyberBiotech
|
18 |
3.6K |
1 |
07/11/25 |
| 07/11/25 |
ASX - By Stock
|
18
|
3.6K
|
1
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Proposed issue of securities - IMC
|
|
CyberBiotech
|
18 |
3.6K |
1 |
07/11/25 |
| 07/11/25 |
ASX - By Stock
|
18
|
3.6K
|
1
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM-529 IND approved by FDA
|
|
CyberBiotech
|
18 |
3.9K |
0 |
06/11/25 |
| 06/11/25 |
ASX - By Stock
|
18
|
3.9K
|
0
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM-529 IND approved by FDA
|
|
CyberBiotech
|
18 |
3.9K |
1 |
06/11/25 |
| 06/11/25 |
ASX - By Stock
|
18
|
3.9K
|
1
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM-529 IND approved by FDA
|
|
CyberBiotech
|
18 |
3.9K |
1 |
05/11/25 |
| 05/11/25 |
ASX - By Stock
|
18
|
3.9K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
CyberBiotech
|
2.8K |
1.0M |
6 |
28/10/25 |
| 28/10/25 |
ASX - By Stock
|
2.8K
|
1.0M
|
6
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
CyberBiotech
|
2.8K |
1.0M |
9 |
27/10/25 |
| 27/10/25 |
ASX - By Stock
|
2.8K
|
1.0M
|
9
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
CyberBiotech
|
92 |
20K |
2 |
17/10/25 |
| 17/10/25 |
ASX - By Stock
|
92
|
20K
|
2
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Submits IMM-529 IND to FDA
|
|
CyberBiotech
|
6 |
1.4K |
2 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
6
|
1.4K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
CyberBiotech
|
1.4K |
551K |
7 |
26/09/25 |
| 26/09/25 |
ASX - By Stock
|
1.4K
|
551K
|
7
|
|
|
ASX - By Stock
|
OCC |
Re:
Predicting OCC to pass $2 by February next year
|
|
CyberBiotech
|
6 |
2.1K |
5 |
26/09/25 |
| 26/09/25 |
ASX - By Stock
|
6
|
2.1K
|
5
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
CyberBiotech
|
2.8K |
1.0M |
13 |
18/09/25 |
| 18/09/25 |
ASX - By Stock
|
2.8K
|
1.0M
|
13
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Compelling 81% Success Rate for Remplir
|
|
CyberBiotech
|
45 |
14K |
5 |
14/09/25 |
| 14/09/25 |
ASX - By Stock
|
45
|
14K
|
5
|
|
|
ASX - By Stock
|
RAD |
Re:
RAD NASDAQ Trading Overnight
|
|
CyberBiotech
|
457 |
124K |
0 |
22/08/25 |
| 22/08/25 |
ASX - By Stock
|
457
|
124K
|
0
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
CyberBiotech
|
2.8K |
1.4M |
0 |
24/07/25 |
| 24/07/25 |
ASX - By Stock
|
2.8K
|
1.4M
|
0
|
|
|
ASX - By Stock
|
IMC |
Re:
Ann: FY25 global sales exceed projection, up 49% on prior year
|
|
CyberBiotech
|
25 |
8.2K |
0 |
18/07/25 |
| 18/07/25 |
ASX - By Stock
|
25
|
8.2K
|
0
|
|
|
ASX - By Stock
|
RAD |
Re:
RAD NASDAQ Trading Overnight
|
|
CyberBiotech
|
457 |
124K |
0 |
10/07/25 |
| 10/07/25 |
ASX - By Stock
|
457
|
124K
|
0
|
|
|
ASX - By Stock
|
RAD |
Re:
RAD NASDAQ Trading Overnight
|
|
CyberBiotech
|
457 |
124K |
0 |
09/07/25 |
| 09/07/25 |
ASX - By Stock
|
457
|
124K
|
0
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Record Revenue of $2.73m in June 25 Quarter up 22.8% QoQ
|
|
CyberBiotech
|
75 |
31K |
12 |
08/07/25 |
| 08/07/25 |
ASX - By Stock
|
75
|
31K
|
12
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Record Revenue of $2.73m in June 25 Quarter up 22.8% QoQ
|
|
CyberBiotech
|
75 |
31K |
1 |
08/07/25 |
| 08/07/25 |
ASX - By Stock
|
75
|
31K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
CyberBiotech
|
2.8K |
1.4M |
2 |
30/06/25 |
| 30/06/25 |
ASX - By Stock
|
2.8K
|
1.4M
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC chart
|
|
CyberBiotech
|
2.8K |
1.4M |
4 |
30/06/25 |
| 30/06/25 |
ASX - By Stock
|
2.8K
|
1.4M
|
4
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First Surgical Use of Remplir in US$1.6 Billion US Market
|
|
CyberBiotech
|
44 |
16K |
2 |
27/06/25 |
| 27/06/25 |
ASX - By Stock
|
44
|
16K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Compelling Data Highlights Remplir Competitive Advantage
|
|
CyberBiotech
|
22 |
10K |
17 |
20/06/25 |
| 20/06/25 |
ASX - By Stock
|
22
|
10K
|
17
|
|
|
ASX - By Stock
|
OCC |
Re:
OCC Broker Data
|
|
CyberBiotech
|
327 |
149K |
8 |
19/06/25 |
| 19/06/25 |
ASX - By Stock
|
327
|
149K
|
8
|
|
|
ASX - By Stock
|
OCC |
Re:
2024/2025 Catalysts
|
|
CyberBiotech
|
291 |
125K |
0 |
17/06/25 |
| 17/06/25 |
ASX - By Stock
|
291
|
125K
|
0
|
|
|
ASX - By Stock
|
OCC |
Re:
2024/2025 Catalysts
|
|
CyberBiotech
|
291 |
125K |
2 |
16/06/25 |
| 16/06/25 |
ASX - By Stock
|
291
|
125K
|
2
|
|
|
ASX - By Stock
|
OCC |
Re:
2024/2025 Catalysts
|
|
CyberBiotech
|
291 |
125K |
11 |
14/06/25 |
| 14/06/25 |
ASX - By Stock
|
291
|
125K
|
11
|
|
|
ASX - By Stock
|
OCC |
Re:
Nearest the pin for Smrtgraft Tendon Repair Approval date
|
|
CyberBiotech
|
73 |
31K |
0 |
10/06/25 |
| 10/06/25 |
ASX - By Stock
|
73
|
31K
|
0
|
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
CyberBiotech
|
1.4K |
551K |
4 |
30/05/25 |
| 30/05/25 |
ASX - By Stock
|
1.4K
|
551K
|
4
|
|